glp·helper
glphelper.com/ozempic/florida/palm-harbor
GLP-1 receptor agonistFDA-approved December 2017Rx · Subcutaneous injection · Once weekly

Ozempic® providers &
prescriptions in Palm Harbor, FL

Verified Ozempic providers in Palm Harbor, FL. Checked against the NPI registry, never ranked by who pays us.[7]

average Ozempic weight loss →trial-anchored estimate
city providers
31
as of today
§ 02Provider directory: Florida
31 of 31 shown

Find an Ozempic provider in Florida.

Every entry is checked against the federal NPI registry. We do not accept payment for placement.

Filter →
Type
Provider
City
Insurance / phone
Browse by Florida city · /ozempic/florida/{city}
§ 03Getting Ozempic in Palm Harbor
31 providers · Palm Harbor, FL

How to get Ozempic in Palm Harbor.

31 GLP-1 prescribers and 7 local resource types are on record for Palm Harbor, plus 3 nearby towns in the directory.

Prescribers in Palm Harbor
31 prescribers
31 GLP-1 prescribers in Palm Harbor, most listed as Family Medicine (14), Internal Medicine (11) and Internal Medicine, Endocrinology, Diabetes & Metabolism (4). Any Florida-licensed physician, nurse practitioner, or PA can prescribe Ozempic, over video or in person. The nearest towns on record are Dunedin (29 providers), Clearwater (36 providers) and Largo (32 providers).
Around the prescription in Palm Harbor
7 listed nearby
20 dietitians, 4 nutritionists, 6 gyms, 6 fitness clubs, 6 trainers, 6 physiotherapists and 4 places to move are on record near Palm Harbor.
Medicaid (weight loss)
Diabetes only
As of April 2026, Florida Medicaid covers GLP-1s for diabetes but not for weight loss. Employer and private plans can still cover them; that is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Florida’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for adults with type 2 diabetes, and, by indirect effect, for body weight.

Ozempic is the brand name for semaglutide, a once-weekly subcutaneous injection in the GLP-1 receptor agonist class. It mimics a gut hormone that signals satiety to the brain and slows gastric emptying. In randomized trials it lowered HbA1c by 1.4 to 1.8 percentage points and produced a mean weight loss of 4.5 to 6.4 kg at the 1 mg dose.[2][3]

It is FDA-approved for glycemic control in adults with type 2 diabetes mellitus and for reducing the risk of major cardiovascular events in adults with T2D and established cardiovascular disease. The same molecule, marketed by the same manufacturer as Wegovy, is the FDA-approved formulation for chronic weight management.[1]

For the receptor story in plain English, read how does ozempic work.

Rapid weight loss can change the midface. The mechanism people call ozempic face is in the research notes.

At a glanceNDC 0169-4132
Generic name
semaglutide
Drug class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
FDA approved
December 2017
Approved use
Type 2 diabetes mellitus (adults)
Off-label use
Weight management (Wegovy is the FDA-approved formulation for obesity)
Administration
Subcutaneous injection · Once weekly
Available doses
0.25 mg · 0.5 mg · 1 mg · 2 mg
Half-life
≈ 7 days
Pregnancy
Discontinue ≥ 2 months before planned pregnancy

Community health · CDC

Weight & metabolic health in Palm Harbor

Palm Harbor, Florida has a population of 61,366 people. The adult obesity rate in Palm Harbor is an age-adjusted estimate of 30.3%, 0.7 percentage points above the Florida state rate of 29.6%. Diagnosed diabetes reaches 8.8% of adults in Palm Harbor. Inactivity, meaning no leisure-time physical activity reported in the past month, affects 19.7% of adults in Palm Harbor.

of Palm Harbor adults have obesity
30.3%
diagnosed diabetes
8.8%
no regular physical activity
19.7%

Age-adjusted estimates for Palm Harbor, community figures, not individual risk. CDC PLACES, 2025 release.

Estimate your weight losshow tirzepatide titration works
§ 05Support around Ozempic in Palm Harbor
4 nutritionists

The prescription is one part. Here is the rest, in Palm Harbor.

Trials of semaglutide paired the drug with diet counseling and regular activity. Every name below is a real listing near Palm Harbor, FL, ordered as the registry lists them, never by who pays us.

Nutritionists

A nutritionist helps you get enough protein and fiber while the medication cuts your appetite. Call to ask what they cover.

Elizabeth Britt
NUTRITIONIST
Nutritionist
31860 Us Highway 19 N
Call 727-787-6335NPI 1700364940
Janice Carlin, PhD, CHHP
NUTRITIONIST
Nutritionist
3816 Pebble Ct
Call 512-466-7263NPI 1407572324
Michael Farris, DCN, MS, LDN, CNS
NUTRITIONIST
Nutritionist
725 Bowsprit Pl
Call 727-233-5365NPI 1528720976
Cassandra Stelogeannis, LDN
NUTRITIONIST
Nutritionist
34921 Us Highway 19 N
Call 727-376-9757NPI 1619676715

Gyms near you

A gym gives you the regular movement that keeps muscle while the weight comes off.

Planet Fitness
GYM
4.3 on Google · 938 reviews
30701 US-19
Website
Crunch Fitness - Palm Harbor
GYM
4.3 on Google · 559 reviews
35104 US Hwy 19 N
Website
John Geigle YMCA
GYM
4.9 on Google · 339 reviews
4550 Village Center Dr
Website
Anytime Fitness
GYM
4.7 on Google · 268 reviews
679 Alderman Rd
Website
Orangetheory Fitness
GYM
4.7 on Google · 206 reviews
33645 US Hwy 19 N
Website
Burn Boot Camp
GYM
4.9 on Google · 111 reviews
30901-31077, 31075 US-19
Website
§ 06Clinical evidence
N = 8,416 across SUSTAIN 1 to 7

What the trials actually showed.

We summarize results from the SUSTAIN program, the seven Phase III randomized trials Novo Nordisk submitted to the FDA, and the SUSTAIN-6 cardiovascular outcomes trial. Numbers below are means at the 30-week endpoint, 1 mg weekly dose.

SUSTAIN 1 through 7 compared semaglutide against placebo, sitagliptin, exenatide ER, insulin glargine, and dulaglutide. Semaglutide produced superior HbA1c and body-weight reductions in every active comparator trial.[3]
SUSTAIN endpoint table1 mg / 30 wk
HbA1c reduction
−1.4 to −1.8%
vs. placebo at 30 wk[3]
Weight change
−4.5 to −6.4 kg
mean, 1 mg dose[3]
Major adverse cardiac events
−26%
HR 0.74 vs. placebo[2]
Patients reaching HbA1c <7%
72%
1 mg dose, 30 wk[3]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Ozempic weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in SUSTAIN trials were nausea (15 to 20%), diarrhea (8 to 9%), and vomiting (5 to 9%), all dose-dependent and typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Contraindicated in personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
15 to 20%
mild
Most common; typically dose-dependent and resolves within weeks
Diarrhea
8 to 9%
mild
More frequent during dose escalation
Vomiting
5 to 9%
mild
Reduced by slower titration
Constipation
3 to 7%
mild
Abdominal pain
5 to 7%
moderate
Pancreatitis
<0.3%
serious
Discontinue if confirmed; black-box adjacent
Gallbladder disease
1.5%
serious
Cholelithiasis risk elevated with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated in MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Cash (no insurance)
$950 to $1,150
per month
National pharmacy average, brand-name[6]
Commercial insurance (covered)
$25 to $250
per month copay
Varies by PBM; T2D indication usually covered
Commercial insurance (off-label / weight)
Typically denied
PA required; majority denied for weight indication
Medicare Part D
$0 to $100
per month
T2D covered; weight loss not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial only; eligibility limits apply
Compounded semaglutide
$150 to $400
per month
503A pharmacies; FDA scrutiny ongoing[8]
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Ozempic providers in Florida

NPI-verified Ozempic (semaglutide) prescribers and clinics, never ranked by who pays us.

Ozempic in other states

Find NPI-verified Ozempic (semaglutide) doctors, clinics, and pharmacies in the states we cover, never ranked by who pays us.

Related GLP-1 research
§ 09Frequently asked: Ozempic in Florida

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Yes. Semaglutide is a federally scheduled prescription drug in all 50 states. A licensed prescriber (MD, DO, NP, or PA) must evaluate you before issuing a prescription. No state permits pharmacist-initiated prescribing of GLP-1s.[1]